Cubist Systematic Strategies, LLC Supernus Pharmaceuticals, Inc. Transaction History
Cubist Systematic Strategies, LLC
- $20.3 Billion
- Q2 2025
A detailed history of Cubist Systematic Strategies, LLC transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 52,794 shares of SUPN stock, worth $2.72 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
52,794
Previous 149,489
64.68%
Holding current value
$2.72 Million
Previous $4.9 Million
66.01%
% of portfolio
0.01%
Previous 0.03%
Shares
29 transactions
Others Institutions Holding SUPN
# of Institutions
316Shares Held
61.2MCall Options Held
18.4KPut Options Held
0-
Black Rock Inc. New York, NY10.4MShares$536 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.21MShares$320 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY4.81MShares$248 Million2.66% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.02MShares$156 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C32.76MShares$142 Million0.11% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $2.76B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...